15.0
Armata Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
27.0
FY23:
19.2
FY24:
11.3
FY25:
10.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
54.8
FY22:
68.8
FY23:
79.2
FY24:
75.1
FY25:
66.2
Total assets
Change from FY21 to FY25
millions USD
FY21:
69.8
FY22:
95.8
FY23:
98.4
FY24:
86.4
FY25:
76.9
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.81
FY22:
24.9
FY23:
16.5
FY24:
48.2
FY25:
8.95
(negative)
Change from FY21 to FY25
millions USD
FY21:
39.6
FY22:
34.9
FY23:
114
FY24:
86.2
FY25:
287
(positive)
Change from FY21 to FY25
millions USD
FY21:
25.4
FY22:
36.1
FY23:
−32.1
FY24:
−48.0
FY25:
−219
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
69.8
FY22:
95.8
FY23:
98.4
FY24:
86.4
FY25:
76.9
All amounts in millions USD